OBIO Announces Expansion of Early Adopter Health Network Partnerships
September 29, 2021
September 29, 2021
TORONTO, ON – September 29, 2021 – The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the growth and expansion of its Early Adopter Health Network (EAHN™) partnerships, together with the upcoming selection round of its new cohort.
With more than 18 healthcare members and 11 innovation organization partners from across Canada, the EAHN™ has grown into Canada’s premier health science market acceleration program since its launch in early 2020. Now, OBIO® will be hosting its third cohort network day in October, where innovative companies will meet with healthcare organizations prior to launching new EAHN™ projects later this year.
“We are delighted to expand the EAHN™ with the engagement of so many leading healthcare organizations and with the support of our innovation organization partners,” said Gail Garland, President & CEO of OBIO®. “Growing and maintaining a robust and globally competitive domestic health science industry ecosystem here in Canada requires partnerships and collaborations to get the job done.”
Through the EAHN™, which is supported by the Federal Economic Development Agency of Southern Ontario, OBIO® provides project management and financial support to evaluate technologies in the real-world setting and facilitate their broad adoption into the health system. They connect leading-edge, scaling health science companies with healthcare organizations, providing an opportunity for innovators to access local markets before expanding globally, as well as a strong reason to anchor themselves in Canada.
Driven by OBIO’s unique capacity to pair commercial-ready technologies with clinical end-users who want to deliver improved care at any health institution, the goal for the EAHN™ is to become early adopters of homegrown medical technology and help streamline the procurement process. Through a collaborative and comprehensive approach, EAHN™ addresses both the “push” and “pull” factors of what industry has developed and what burdened hospitals are trying to address. This allows the EAHN™ to catalyze change by delivering improved patient care more efficiently while opening the door to a new health-care economy that benefits Canadians and Canadian companies alike.
OBIO® would like to thank and recognize the following organizations for their involvement and support in the EAHN™:
EAHN™ Healthcare Members:
EAHN™ Innovation Organization Partners:
For more information about OBIO’s EAHN™, or if you are interested in being part of the network, please contact Dr. Jeff Aramini at email@example.com.
OBIO®, founded in 2009, is a not-for-profit, membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies positioning Canada as a leader in the international marketplace. OBIO® advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.
For media inquiries, please contact:
Bojana Duric, BlueSky Communications